Your session is about to expire
← Back to Search
Behavioural Intervention
inspiratory muscle program for Lung Cancer (CT0076 Trial)
N/A
Waitlist Available
Led By Moishe Liberman, MD, PhD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days after surgery
Awards & highlights
CT0076 Trial Summary
This trial investigates whether a preoperative inspiratory muscle exercises program can reduce pulmonary complications after thoracic surgery.
Eligible Conditions
- Lung Cancer
CT0076 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30 days after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days after surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Numbers of postoperative pulmonary complications
Secondary outcome measures
Length of stay (by days)
Numbers of morbidity and mortality
CT0076 Trial Design
2Treatment groups
Experimental Treatment
Group I: no inspiratory muscle programExperimental Treatment1 Intervention
standard of care: postoperative spirometry with enhanced recovery program in thoracic surgery
Group II: inspiratory muscle programExperimental Treatment1 Intervention
Inspiratory muscle training preoperative with standard of care
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,496 Total Patients Enrolled
Moishe Liberman, MD, PhDPrincipal InvestigatorCHUM
16 Previous Clinical Trials
1,090 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger